LINC00460 Promotes Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Head and Neck Squamous Cell Carcinoma via miR-320a/BGN Axis

References

• Wyss A, Hashibe M, Chuang SC, et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the international head and neck cancer epidemiology consortium. Am J Epidemiol. 2013;178(5):679–690. doi:10.1093/aje/kwt029
   PubMed Web of Science ®Google Scholar
• Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer. 2018;18(5):269–282. doi:10.1038/nrc.2018.11
   PubMed Web of Science ®Google Scholar
• Gatta G, Botta L, Sánchez MJ, Anderson LA, Pierannunzio D, Licitra L. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study. Eur J Cancer. 2015;51(15):2130–2143. doi:10.1016/j.ejca.2015.07.043
   PubMed Web of Science ®Google Scholar
• Yang J, Antin P, Berx G, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21(6):341–352. doi:10.1038/s41580-020-0237-9
   PubMed Web of Science ®Google Scholar
• Thierauf J, Veit JA, Hess J. Epithelial-to-mesenchymal transition in the pathogenesis and therapy of head and neck cancer. Cancers. 2017;9(12):7. doi:10.3390/cancers9070076
   PubMedGoogle Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407. doi:10.1016/j.cell.2018.01.011
   PubMed Web of Science ®Google Scholar
• Yang J, Lian Y, Yang R, et al. Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes. Mol Ther Nucleic Acids. 2020;19:1164–1175. doi:10.1016/j.omtn.2019.12.041
   PubMedGoogle Scholar
• Li K, Sun D, Gou Q, et al. Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells. Cancer Lett. 2018;420:80–90. doi:10.1016/j.canlet.2018.01.060
   PubMed Web of Science ®Google Scholar
• Feng L, Rao M, Zhou Y, Zhang Y, Zhu Y. Long noncoding RNA 00460 (LINC00460) promotes glioma progression by negatively regulating miR-320a. J Cell Biochem. 2019;120(6):9556–9563. doi:10.1002/jcb.28232
   PubMed Web of Science ®Google Scholar
• Jiang Y, Cao W, Wu K, et al. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. J Exp Clin Cancer Res. 2019;38(1):365. doi:10.1186/s13046-019-1364-z
   PubMed Web of Science ®Google Scholar
• Budach V, Tinhofer I. Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review. Lancet Oncol. 2019;20(6):e313–e326. doi:10.1016/S1470-2045(19)30177-9
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Puram SV, Tirosh I, Parikh AS, et al. Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell. 2017;171(7):1611–1624.e1624. doi:10.1016/j.cell.2017.10.044
   PubMed Web of Science ®Google Scholar
• Esposito R, Bosch N, Lanzós A, Polidori T, Pulido-Quetglas C, Johnson R. Hacking the cancer genome: profiling therapeutically actionable long non-coding RNAs using CRISPR-Cas9 Screening. Cancer Cell. 2019;35(4):545–557. doi:10.1016/j.ccell.2019.01.019
   PubMed Web of Science ®Google Scholar
• Zhang XZ, Liu H, Chen SR. Mechanisms of long non-coding RNAs in cancers and their dynamic regulations. Cancers. 2020;12:5. doi:10.3390/cancers12051245
   Web of Science ®Google Scholar
• Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol. 2019;20(1):5–20. doi:10.1038/s41580-018-0059-1
   PubMed Web of Science ®Google Scholar
• Hong H, Zhu H, Zhao S, et al. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression. Cell Death Dis. 2019;10(12):950. doi:10.1038/s41419-019-2183-z
   PubMedGoogle Scholar
• Lv G, Wu M, Wang M, et al. miR-320a regulates high mobility group box 1 expression and inhibits invasion and metastasis in hepatocellular carcinoma. Liver Int. 2017;37(9):1354–1364. doi:10.1111/liv.13424
   PubMed Web of Science ®Google Scholar
• Yuan Z, Xiu C, Song K, et al. Long non-coding RNA AFAP1-AS1/miR-320a/RBPJ axis regulates laryngeal carcinoma cell stemness and chemoresistance. J Cell Mol Med. 2018;22(9):4253–4262. doi:10.1111/jcmm.13707
   PubMed Web of Science ®Google Scholar
• Roedig H, Damiescu R, Zeng-Brouwers J, et al. Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development. Semin Cancer Biol. 2020;62:31–47.
   PubMed Web of Science ®Google Scholar
• Huang HC, Cai BH, Suen CS, et al. BGN/TLR4/NF-B mediates epigenetic silencing of immunosuppressive siglec ligands in colon cancer cells. Cells. 2020;9:2. doi:10.3390/cells9020397
   Web of Science ®Google Scholar
• Jacobsen F, Kraft J, Schroeder C, et al. Up-regulation of biglycan is associated with poor prognosis and PTEN deletion in patients with prostate cancer. Neoplasia. 2017;19(9):707–715. doi:10.1016/j.neo.2017.06.003
   PubMed Web of Science ®Google Scholar
• Hong W, Ying H, Lin F, Ding R, Wang W, Zhang M. lncRNA LINC00460 Silencing Represses EMT in Colon Cancer through Downregulation of ANXA2 via Upregulating miR-433-3p. Mol Ther Nucleic Acids. 2020;19:1209–1218. doi:10.1016/j.omtn.2019.12.006
   PubMedGoogle Scholar
• Chou LF, Chen CY, Yang WH, et al. Suppression of hepatocellular carcinoma progression through FOXM1 and EMT Inhibition via Hydroxygenkwanin-Induced miR-320a Expression. Biomolecules. 2019;10:1. doi:10.3390/biom10010020
   PubMed Web of Science ®Google Scholar
• Zhang HH, Li R, Li YJ, et al. eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF‑β1‑induced epithelial‑mesenchymal transition. Oncol Rep. 2020;43(2):447–460.
   PubMedGoogle Scholar
• Thakur AK, Nigri J, Lac S, et al. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death Differ. 2016;23(8):1358–1370. doi:10.1038/cdd.2016.18
   PubMed Web of Science ®Google Scholar
• Li H, Zhong A, Li S, et al. The integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis. Sci Rep. 2017;7(1):4915. doi:10.1038/s41598-017-05280-6
   PubMedGoogle Scholar